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Abstract
Background: In the developing vertebrate peripheral nervous system, the survival of sympathetic neurons and the
majority of sensory neurons depends on a supply of nerve growth factor (NGF) from tissues they innervate.
Although neurotrophic theory presupposes, and the available evidence suggests, that the level of NGF expression
is completely independent of innervation, the possibility that innervation may regulate the timing or level of NGF
expression has not been rigorously investigated in a sufficiently well-characterized developing system.
Results: To address this important question, we studied the influence of innervation on the regulation of NGF
mRNA expression in the embryonic mouse maxillary process in vitro and in vivo. The maxillary process receives its
innervation from predominantly NGF-dependent sensory neurons of the trigeminal ganglion and is the most
densely innervated cutaneous territory with the highest levels of NGF in the embryo. When early, uninnervated
maxillary processes were cultured alone, the level of NGF mRNA rose more slowly than in maxillary processes
cultured with attached trigeminal ganglia. In contrast to the positive influence of early innervation on NGF mRNA
expression, the levels of brain-derived neurotrophic factor (BDNF) mRNA and neurotrophin-3 (NT3) mRNA rose to
the same extent in early maxillary processes grown with and without trigeminal ganglia. The level of NGF mRNA,
but not BDNF mRNA or NT3 mRNA, was also significantly lower in the maxillary processes of erbB3
-/- mice, which
have substantially fewer trigeminal neurons than wild-type mice.
Conclusions: This selective effect of initial innervation on target field NGF mRNA expression provokes a re-
evaluation of a key assertion of neurotrophic theory that the level of NGF expression is independent of innervation.
Background
Neurotrophic theory provides a widely accepted explana-
tion for how the number of neurons in the developing
nervous system is matched to the size and requirements
of the targets they innervate. The basic idea is that neu-
rons, which are generated in excess during the early
stages of development, depend for their survival on the
supply of a neurotrophic factor produced by their targets.
The targets produce just the right amount of neuro-
trophic factor to support the required number of neu-
rons, and superfluous neurons are eliminated in a phase
of cell death shortly after the onset of target innervation
[1]. Neurotrophic theory is endorsed by a large body of
work on nerve growth factor (NGF), the first neuro-
trophic factor to be identified, and has been corroborated
by studies of other members of the NGF family of neuro-
trophins. Most importantly, NGF has been shown to be
produced in the targets of NGF-dependent neurons in
proportion to their final innervation density, experimen-
tal manipulation of the availability of NGF during devel-
opment influences the number of NGF-dependent
neurons that survive and target-derived NGF is retrogra-
dely transported in endosomes that generate survival sig-
nals in cell bodies of the innervating neurons [2-4].
Implicit in the proposal that targets control their innerva-
tion density is the assertion that the level of neurotrophic
factor synthesis in the target is regulated independently
of its innervation. Indeed, the finding in chicken embryos
that removal of the neural primordial cells that give rise
to neurons that innervate the leg does not prevent NGF
* Correspondence: daviesalun@cf.ac.uk
† Contributed equally
Molecular Biosciences Research Division, Life Sciences Building, School of
Biosciences, Museum Avenue, Cardiff CF10 3AT, UK
Wyatt et al. Neural Development 2011, 6:18
http://www.neuraldevelopment.com/content/6/1/18
© 2011 Wyatt et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.mRNA expression in uninnervated leg skin demonstrates
that NGF expression can occur independently of innerva-
tion [5]. Likewise, the developmental rise in ventricular
NGF mRNA is unaffected by sympathectomy part way
through this rise [6].
We revisited the issue of the influence of innervation on
target field expression of NGF in the most densely inner-
vated cutaneous target with the highest level of NGF
synthesis in mouse embryos [7], the maxillary process
from which the mystacial whisker pad arises. NGF mRNA
expression in the maxillary process commences at
embryonic day (E)10.5 and increases with age to peak at
E15, with the highest levels in the epithelium [8]. Brain-
derived neurotrophic factor (BDNF) mRNA and neurotro-
phin-3 (NT3) mRNA are detectable in the maxillary
process anlagen at E9.5 and peak at E12 and E13, respec-
tively, with the highest levels in the mesenchyme [9]. The
earliest axons emerge from the trigeminal ganglion at E9.5
and reach the maxillary epithelium by E11 [10]. The ear-
liest trigeminal neurons depend on NT3 and BDNF for
survival, and while some of these neurons soon switch to
become NGF-dependent, most NGF-dependent neurons
are generated in a wave of neurogenesis between E11.5
and E13.5 [11,12]. With the onset of neuronal loss in the
trigeminal ganglion at E13 [10], the great majority of neu-
rons are dependent on NGF for survival [9,13].
Results
Influence of innervation on neurotrophin expression
in vitro
We began investigating the influence of innervation on
neurotrophin expression by culturing early maxillary
processes with and without attached trigeminal ganglia.
These explants were grown in the centre of a Matrigel
matrix to maintain their anatomical integrity and were
bathed in defined, serum-free medium containing NGF,
BDNF and NT3 to maintain optimal neuronal survival.
The levels of NGF, BDNF and NT3 mRNAs in the
innervated and uninnervated maxillary process explants
were quantified using a very sensitive competitive RT-
PCR method [14]. The levels of these transcripts are
expressed relative to the level of the mRNA for the
house-keeping enzyme glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) to correct for any small differ-
ences in the size of dissected tissue. These cultures were
set up at stages when the earliest trigeminal axons reach
and begin to innervate the maxillary process in vivo,
namely, at E10.5 when small numbers of trigeminal
axons are starting to grow into the maxillary mesench-
yme and at E11 when the first axons come into proxi-
mity with the maxillary epithelium [10], where the
highest levels of NGF mRNA are expressed later in
development [8]. The explants were incubated for 48
hours in vitro (equivalent to E12.5 in vivo for E10.5
explants and E13 for E11 explants), and thus encom-
passed the period of development when the levels of
NGF, BDNF and NT3 mRNAs are rising rapidly [8,9] as
increasing numbers of trigeminal axons reach and inner-
vate the maxillary target in vivo [10].
Figure 1 shows that the levels of all three neurotro-
phin mRNAs increased markedly in E10.5 and E11 max-
illary processes cultured for 48 hours relative to the
levels in freshly dissected maxillary processes. However,
whereas the levels of BDNF and NT3 mRNAs increased
to the same extent in maxillary processes grown with
and without attached trigeminal ganglia, the levels of
NGF mRNA were significantly higher in maxillary pro-
cesses that retained intact connections with trigeminal
ganglia compared with maxillary processes grown alone.
The enhanced levels of NGF mRNA in maxillary pro-
cesses grown with trigeminal ganglia were higher and
more significant in E10.5 co-cultures (52% higher, P <
0.001, t-test, n = 23) than in E11 co-cultures (14%
higher, P < 0.05, t-test, n = 24). The elevated level of
NGF mRNA in the maxillary process of co-cultures was
unlikely to have been simply due to the trigeminal gang-
lion improving the viability or increasing growth of
maxillary tissue because the levels of BDNF and NT3
mRNAs were no higher in the same maxillary processes
(Figure 1).
The selective influence of trigeminal ganglia on NGF
mRNA expression could be due to either the presence
of increasing numbers of trigeminal axons reaching and
innervating the maxillary process from the attached
ganglion or to the action of a diffusible agent from the
trigeminal ganglion acting on NGF-producing cells
within the attached maxillary processes. To investigate
whether trigeminal ganglia could affect NGF mRNA
expression in early maxillary processes without innervat-
ing them, E10.5 maxillary processes and trigeminal
ganglia were separated and cultured with a small gap
between them. In these co-cultures and in cultures in
which single maxillary processes were surrounded by a
rosette of six closely apposed trigeminal ganglia and cul-
tured for up to 60 hours, the level of NGF mRNA in
maxillary processes co-cultured with trigeminal ganglia
was not significantly different from the level of NGF
mRNA in maxillary processes grown in isolation (data
not shown). This suggests that anatomically appropriate
innervation of the maxillary process by trigeminal axons
is required for the selective increase in NGF mRNA
expression. Taken together, these in vitro findings sug-
gest that sensory innervation selectively enhances NGF
mRNA expression in the developing maxillary process
but does not influence expression of either BDNF
mRNA or NT3 mRNA.
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Figure 1 Levels of NGF, BDNF and NT3 mRNA relative to GAPDH mRNA in maxillary processes dissected from E10.5 and E11 embryos
and either not cultured (Mx 0 hours) or cultured for 48 hours alone (Mx 48 hours) or with the trigeminal ganglion attached (Mx + TG
48 hours). Statistically significant differences in neurotrophin mRNA levels between maxillary processes cultured for 48 hours alone and maxillary
processes cultured with attached trigeminal ganglia were only observed in the case of NGF mRNA: *P < 0.05 (n = 24); **P < 0.001 (n = 23).
Means ± standard errors of the mean are shown.
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in vivo
To obtain in vivo evidence for the physiological rele-
vance of the above in vitro observations, we quantified
neurotrophin mRNA levels in the maxillary processes of
embryos that have markedly reduced numbers of tri-
geminal neurons during the early stages of maxillary
innervation. Histological analysis of several potentially
appropriate transgenic lines revealed that mice deficient
in the ErbB3 neuregulin receptor were especially suita-
ble for these studies. ErbB3
-/- embryos lack Schwann
cells and their precursors and lose 82% of lumbar dorsal
root ganglia sensory neurons between E12.5 and E18
[15]. In the trigeminal ganglia of erbB3
-/- embryos we
found massive loss of neurons beginning much earlier
in development than in dorsal root ganglia, with 67%
fewer neurons at E11 and 83% fewer by E12 (Figure
2A). This loss was accompanied by a 73% reduction in
the level of TrkC mRNA (Figure 2B) and a 98% reduc-
tion in the level of TrkA mRNA (Figure 2C) in the tri-
geminal ganglia of E12 erbB3
-/- embryos compared with
wild-type littermates. Most TrkA-expressing, NGF-
dependent neurons in the trigeminal ganglion are born
after TrkB/TrkC-expressing, BDNF/NT3-dependent
neurons or are derived from the latter by a developmen-
tal switch in Trk expression [9,11-13]. The virtually
complete loss of TrkA expression in trigeminal ganglia
of erbB3
-/- embryos by E12 implies the elimination of
almost all NGF-responsive trigeminal neurons by this
early stage of development.
Figure 3 shows that there were similar levels of NGF
mRNA in the maxillary processes of erbB3
-/- and erbB3
+/+
embryos at E11, but by E12 there was a highly significant
18% reduction in the level of NGF mRNA in the maxillary
processes of erbB3
-/- embryos compared with wild-type lit-
termates (P = 0.015, t-test, n = 34 embryos). By E13,
although the level of NGF mRNA in the maxillary pro-
cesses of erbB3
-/- embryos was just over 9% lower than in
wild-type littermates, this difference did not reach statisti-
cal significance (P = 0.066, t-test, n = 28 embryos). In
marked contrast to the highly significant differences in the
levels of NGF mRNA at E12, the levels of BDNF mRNA
and NT3 mRNA were not significantly different in the
maxillary processes of erbB3
-/- and erbB3
+/+ embryos at
this age. There were also no apparent differences in the
size or appearance of the maxillary processes of erbB3
-/-
and erbB3
+/+ embryos. These data suggest that early defi-
ciencies in sensory innervation selectively impair the nor-
mal early developmental increase in NGF mRNA
expression in the maxillary target in vivo.
Discussion
We have shown that disrupting the early stages of max-
illary process innervation by the trigeminal ganglion
impedes the developmental increase in NGF mRNA in
this cutaneous target field without affecting the magni-
tude of concomitant developmental increases in the
expression of BDNF mRNA and NT3 mRNA. This
selective impairment in NGF mRNA expression was
most pronounced in maxillary processes cultured in iso-
lation at E10.5 before any sensory axons had reached
the cutaneous epithelium, the predominant site of NGF
synthesis [8]. Maxillary processes cultured in isolation at
E11, after the earliest sensory axons had reached the
epithelium [10], still had significantly lower levels of
NGF mRNA compared with maxillary processes cul-
tured with attached ganglia, but the relative reduction
was less than in isolated E10.5 explants. This suggests
that the arrival of the earliest sensory axons in the
developing maxillary process selectively enhances NGF
mRNA expression. Although not all sensory neurons
that innervate the maxillary process are eliminated in
erbB3
-/- embryos, and analysis of the relative levels of
TrkC and TrkA mRNA in the early trigeminal ganglia
of these embryos suggests that later-generated NGF-
responsive neurons are more greatly depleted than
early-generated NT3-responsive neurons, there is none-
theless a highly significant reduction in NGF mRNA in
the maxillary process of ErbB3-deficient embryos com-
pared with wild-type embryos at E12. Taken together,
these in vitro and in vivo findings suggest that while the
timing and level of NGF mRNA expression in the maxil-
lary cutaneous target field is principally controlled by an
intrinsic developmental programme operating in this
target field, the arrival of sensory axons does selectively
enhances NGF mRNA expression. Thus, early develop-
mental changes in the level of NGF mRNA in the maxil-
lary process are not fully independent of innervation.
What developmental role does innervation-dependent
NGF regulation play? One possibility is that it contributes
to the establishment of regional differences in NGF
mRNA expression. In the trigeminal system, the epithelia
of the developing maxillary, mandibular and ophthalmic
innervation territories express different levels of NGF
mRNA at the commencement of the period of naturally
occurring neuronal death that are correlated with innerva-
tion density [7]. Because the same percentage of neuronal
death occurs in the subsets of trigeminal neurons that
innervate each of these territories, the regional differences
in NGF expression do not sculpt out regional differences
in innervation density but maintain them throughout the
period of naturally occurring neuronal death [10]. Thus, it
is possible the initial regional differences in the numbers
of sensory axons reaching these territories may help set
the corresponding level of NGF expression in each
territory.
An alternative, more plausible role for innervation-
dependent NGF regulation is that it helps coordinate the
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cing wave of sensory axons reaching the target field. This
idea is consistent with the developmental lag in NGF
mRNA expression in erbB3
-/- embryos compared to wild-
type littermates. When the first few axons reach the max-
illary epithelium at E11, there is no difference in the low
levels of NGF mRNA in the maxillary processes of
erbB3
-/- and erbB3
+/+ embryos, but by E12 when large
numbers of axons are beginning to arrive in the maxillary
process in normal development, there is a highly signifi-
cant reduction in the level of NGF mRNA in ErbB3-
deficient embryos. However, by E13, the level of NGF
mRNA in the maxillary process of erbB3
-/- embryos has
begun to catch up with the level in erbB3
+/+ embryos.
Thus, these findings would appear to reveal the operation
of a mechanism that helps coordinate the timing of
trophic interactions between neurons and their targets
during development. A similar mechanism has been pro-
posed for coordinating the onset of neurotrophin depen-
dence in certain populations of sensory neurons with the
arrival of their axons at their targets [16]. In nodose
ganglion neurons, whose axons have a comparatively
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Figure 2 Loss of neurons and reduced levels of TrkC and TrkA mRNA in the trigeminal ganglia of erbB3
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Page 5 of 8long distance to grow to reach their targets and have a
correspondingly protracted period of neurotrophin-inde-
pendent survival before they become dependent on
BDNF for survival [16,17], the onset of BDNF depen-
dence can be accelerated in culture by briefly exposing
the neurons to BDNF toward the end of the period of
neurotrophin independence [16]. Thus, neurotrophin-
promoted acquisition of neurotrophin dependence and
innervation-dependent regulation of target field expres-
sion of NGF may, in certain neuronal systems, contribute
to the temporal coordination of trophic interactions
between neurons and their targets during development.
Our finding that the developmental increase in NT3
mRNA in the maxillary process is independent of inner-
vation agrees with the demonstration that NT3 mRNA
expression in the limb bud is also independent of
sensory innervation [18]. However, our demonstration
that early sensory innervation enhances NGF mRNA
expression in the maxillary process conflicts with the
conclusion, based on studies of the consequences of dis-
rupting innervation to the developing limb bud and
heart, that the level of NGF mRNA expression in the
targets of NGF-dependent neurons is independent of
innervation [5,6]. While modulation of NGF mRNA
expression by innervation may not be a universal feature
of the target fields of all NGF-dependent populations of
neurons, it is possible that the very high levels of NGF
mRNA and dense innervation of the maxillary process
together with the very sensitive competitive RT-PCR
method used in our study have facilitated detection of
the effects of early innervation on NGF mRNA expres-
sion. Furthermore, if NGF mRNA expression is
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reach the target field as part of a mechanism to coordi-
nate the onset of NGF synthesis with the onset of inner-
vation, it would be necessary to disrupt the very earliest
stages of target field innervation and study the conse-
quences of such disruption during these same early
stages in order to observe an effect on NGF mRNA
expression. In the study of chicken embryo limb bud
innervation, while successful removal of the neural pri-
mordial cells that give rise to the neurons that innervate
the limb would have eliminated innervation from the
outset, the consequences for NGF mRNA expression
were not first studied until 3 days after the earliest sen-
sory axons would have normally reached their cutaneous
targets [5], with the possibility that any early effect on
NGF mRNA expression might have been missed. In the
study of postnatal rat heart innervation, chemical sym-
pathectomy did not commence until 5 days after the
earliest sympathetic axons had reached the targets [6],
which might have been too late to observe an early
effect of the arrival of sympathetic axons on target field
expression of NGF.
The cellular and molecular mechanisms by which early
sensory innervation selectively influences NGF expres-
sion in the cutaneous target field of the developing maxil-
lary process are important unanswered questions.
Whether this requires direct cell-cell contact and signal-
ling between the arriving axons and the NGF-producing
cells in this target field or whether it depends on the
synthesis and release of some signalling molecule by the
early axons remains to be determined. It is also feasible
that the Schwann cell precursors that accompany the
early axons into the target field might provide the signal
that modulates NGF expression. It will also be important
to determine whether the level of expression of NGF and
possibly other neurotrophins is also partly regulated by
early innervation elsewhere in the embryo. Finally, to
provide an understanding of the developmental signifi-
cance of the fine temporal modulation of NGF expression
by early innervation, it will be instructive to interfere with
the underlying signalling mechanism that mediates this
and study the consequences for the regulation of neuro-
nal survival and the patterning of innervation.
Conclusions
Our findings provoke a reassessment of a key tenet of
neurotrophic theory, the assertion that neurotrophic fac-
tor expression in the target is regulated completely inde-
pendently of its innervation. Our demonstration of the
selective enhancement of NGF mRNA expression in the
maxillary process by early sensory innervation suggests
the operation of a mechanism that helps coordinate the
timing of trophic interact i o n sb e t w e e nn e u r o n sa n d
their targets. This may be important to ensure NGF is
produced at the right time to sustain the survival of the
earliest neurons to innervate their targets.
Materials and methods
Cultures
Maxillary processes alone or with the adjoining tissue
that contains the entire trigeminal ganglion were dis-
sected from E10.5 and E11 mouse embryos (Theiler
stages 17 and 18, respectively) obtained from overnight
matings of CD1 mice. Each explant was cultured sepa-
rately in a single well of Nunclon 4-well dishes in a 40
μl Matrigel matrix (BD Biosciences, Oxford, Oxford-
shire, UK with 0.5 ml of defined medium [19] supple-
mented with 10 ng/ml NGF, 10 ng/ml BDNF and 10
ng/ml NT3. These neurotrophins were included to
ensure optimal neuronal survival in explants containing
trigeminal ganglia, but were also included in the med-
ium used for culturing maxillary processes on their own
to keep culture conditions the same.
Measurement of mRNA levels
NGF, BDNF, NT3, TrkA, TrkC and GAPDH mRNA levels
were measured in total RNA extracted from maxillary pro-
cesses or trigeminal ganglia by competitive RT-PCR [14].
Briefly, known amounts of cRNA transcripts representing
NGF, BDNF, NT3, TrkA, TrkC and GAPDH coding
sequences were added to reverse transcription reactions
that contained total RNA extracted from maxillary pro-
cesses. Reverse transcription reactions were performed
using Superscript reverse transcriptase (Invitrogen Paisley,
Renfrewshire, UK according to the manufacturers’ proto-
col. The cRNA transcripts of the genes were transcribed
in vitro from a corresponding cloned cDNA copy of the
genes that had been modified to add four base pairs in
between the forward and reverse PCR assay primers. PCR
amplification of cDNA was performed using Helena Bios-
ciences Taq and gene-specific primers according to the
Taq manufacturers’ protocol (Helena Biosciences, Gates-
head, Tyne and Wear, UK). Following PCR, the RT-PCR
products of the endogenous mRNA and the competitor
cRNA were separated on 8% polyacrylamide gels and
stained with SYBR Gold Molecular Probes (Invitrogen
Paisley, Renfrewshire, UK. Images of stained gels were
captured on a gel documentation apparatus and image
analysis software was used to determine the ratio between
the RT-PCR products of the endogenous mRNA and the
competitor cRNA, therefore allowing quantification of
mRNA levels in the original RNA sample. The primer
sequences were: NT3 forward, 5’-TACTACGGCAA-
CAGA GACG-3’; NT3 reverse, 5’-GTTGCCCACA-
TAATCCTCC-3’;N G Ff o r w a r d ,5 ’-AGCATTCCCTT
GACACAG-3’;N G Fr e v e r s e ,5 ’-GGTCTACAGT-
GATGTTGC-3’;B D N Ff o r w a r d ,5 ’-ACTTGGCCTACC-
CAGGTGTG-3’;B D N Fr e v e r s e ,5 ’-TGTCGTCGTCA
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Page 7 of 8GACCTCTCG-3’; TrkA forward, 5’-CGTCATGGCTGCT
TTTATGG-3’; TrkA reverse, 5’-ACTGGCGAGAAGGA-
GACAG-3’; TrkC forward, 5’-CCCACCAAAGACAA-
GATG-3’; TrkC reverse, TATCCAGTCCACATCAGG-3’;
GAPDH forward, 5’-TCCAGTATGACTCCACTCAC-3’;
GAPDH reverse, 5’-TCCTGGAAGATGGTGATGG-3’.
Annealing temperatures for the NT3, NGF, BDNF, TrkA,
TrkC and GAPDH primers were 55°C, 50°C, 60°C 56°C,
52°C and 51°C, respectively.
Quantification of the number of neurons in the trigeminal
ganglia
The heads from E11 and E12 ErbB3-/- and wild-type lit-
termates were fixed for 5 and 15 minutes, respectively, in
Carnoy’s fluid (60% ethanol, 30% chloroform, and 10% gla-
cial acetic acid). Following dehydration through a graded
alcohol series, the tissue was paraffin wax embedded.
Serial sections of the heads were cut at 8 μma n dw e r e
mounted onto poly-lysine-coated slides (VWR, Radnor,
Pennsylvania, USA or Gold Seal Ultrastick Slides (Erie
Scientific, Portsmouth, New Hampshire, USA. To identify
all neurons in these sections, the sections were stained for
bIII-tubulin. Sections were cleared in xylene and rehy-
drated prior to quenching in 0.3% hydrogen peroxide and
10% methanol in PBS for 20 minutes. Non-specific anti-
body binding was blocked in 10% horse serum, 0.4% Tri-
ton X-100 in PBS prior to incubation with mouse anti-bIII
tubulin antibody (Promega, Madison, Wisconsin, USA
diluted 1:2,000 in PBS overnight at 4°C. The cells were
then labelled using biotinylated secondary antibody
(1:200), avidin, biotinylated horseradish peroxidase macro-
molecular complex (Vectastain ABC Kit, Vector Labs,
Burlingame, California, USA. The substrate used for the
reaction was 1 mg/ml diaminobenzidine tetrachloride
(FastDAB, Sigma-Aldrich, St Louis, Missouri, USA. Neu-
ronal number was quantified using a digital stereology sys-
tem that employs a combination of the optical dissector
and volume fraction/Cavalieri methods (Kinetics Imaging,
Ltd., Bromborough, Merseyside, UK.
Abbreviations
BDNF: brain-derived neurotrophic factor; E: embryonic day; GAPDH:
glyceraldehyde 3-phosphate dehydrogenase; NGF: nerve growth factor; NT3:
neurotrophin-3; PBS: phosphate-buffered saline; Trk: tyrosine receptor kinase.
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